Conditioning response to granulocyte colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase complex

Journal of Leukocyte Biology

Volumn 84, Issue 2, 2008, Pages 331-337

  Focosi, Daniele ^a   Kast, Richard Eric ^b   Galimberti, Sara ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow; CXCL12; DPP IV; G CSF; Gliptins; Hematopoietic stem cells; Sitagliptin

Indexed keywords

ADENOSINE DEAMINASE; ALPHA INTERFERON; CHEMOKINE RECEPTOR CXCR4; CLADRIBINE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIPROTIN A; DIPYRIDAMOLE; FLUDARABINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; LITHIUM; METFORMIN; METHOTREXATE; PENTOSTATIN; PROPRODIPHENYL PHOSPHONATE; RETINOIC ACID; SAXAGLIPTIN; SITAGLIPTIN; STROMAL CELL DERIVED FACTOR 1ALPHA; VILDAGLIPTIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL HOMING; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFECT; ENGRAFTMENT; ENZYME INHIBITION; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL MOBILIZATION; TREATMENT OUTCOME;

ADENOSINE DEAMINASE; ANIMALS; ANTIGENS, CD26; BLOOD COMPONENT REMOVAL; BONE MARROW CELLS; CHEMOKINE CXCL12; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LYMPHOKINES; RECEPTORS, CXCR4;

EID: 48649107640     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0208109     Document Type: Review

References (106)

1. Hoglund, M., Smedmyr, B., Bengtsson, M., Totterman, T., Cour-Chabernaud, V., Yver, A., Simonsson, B. (1997) Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers - a comparative study. Eur. J. Haematol. 59, 177-183.
2. Malerba, L., Mele, A., Leopardi, G., Stramigioli, S., Politi, P., Visani, G. (2006) Pegfilgrastim effectively mobilizes PBSC in a poor mobilizer multiple myeloma patient. Eur. J. Haematol. 76, 436-439.
3. Togel, F., Isaac, J., Westenfelder, C. (2004) Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. J. Am. Soc. Nephrol. 15, 1261-1267.
4. Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., Lider, O., Alon, R., Zipori, D, Lapidot, T. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-848.
5. Pelus, L., Fukuda, S. (2006) Peripheral blood stem cell mobilization: the CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp. Hematol. 34, 1010-1020.
6. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., Rafii, S. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637.
7. Dawson, M., Schwarer, A., Muirhead, J., Bailey, M., Bollard, G., Spencer, A. (2005) Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen. Bone Marrow Transplant. 36, 389-396.
8. Carlo-Stella, C., Di Nicola, M., Milani, R., Guidetti, A., Magni, M., Milanesi, M., Longoni, P., Matteucci, P., Formelli, F., Ravagnani, F., Corradini, P., Gianni, A. M. (2004) Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood 103, 3287-3295.
9. Nardini, E., Morelli, D., Aiello, P., Besusso, D., Calcaterra, C., Mariani, L., Palazzo, M., Vecchi, A., Paltrinieri, S., Menard, S., Balsari, A. (2005) CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production. J. Cell. Physiol. 204, 889-895.
10. Watanabe, T., Kawano, Y., Kanamaru, S., Onishi, T., Kaneko, S., Wakata, Y., Nakagawa, R., Makimoto, A., Kuroda, Y., Takaue, Y., Talmadge, J. (1999) Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Blood 93, 1157-1163.
11. Velders, G., Pruijt, J., Verzaal, P., van Os, R., van Kooyk, Y., Figdor, C., de Kruijf, E., Willemze, R., Fibbe, W. E. (2002) Enhancement of G-CSF-induced stem cell mobilization by antibodies against the β 2 integrins LFA-1 and Mac-1. Blood 100, 327-333.
12. King, A. G., Horowitz, D., Dillon, S. B., Levin, R., Farese, A. M., MacVittie, T. J., Pelus, L. M. (2001) Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRO{β}. Blood 97, 1534-1542.
13. Pelus, L., Bian, H., Fukuda, S., Wong, D., Merzouk, A., Salari, H. (2005) The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp. Hematol. 33, 295-307.
14. Martin, C., Bridger, G., Rankin, S. (2006) Structural analogues of AMD3100 mobilize hematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro. Br. J. Haematol. 134, 326-329.
15. Fazzi, R., Testi, R., Trasciatti, S., Galimberti, S., Rosini, S., Piras, F., L'Abbate, G., Conte, A., Petrini, M. (2002) Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice. Leuk. Res. 26, 19-27.
16. Fazzi, R., Galimberti, S., Testi, R., Pacini, S., Trasciatti, S., Rosini, S., Petrini, M. (2002) Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cells. Leuk. Res. 26, 839-848.
17. Ballen, K., Shpall, E., Avigan, D., Yeap, B., Fisher, D., McDermott, K., Dey, B., Attar, E., McAfee, S., Konopleva, M., Antin, J., Spitzer, T. (2007) Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol. Blood Marrow Transplant. 13, 838-843.
18. Fibbe, W., Pruijt, J., Velders, G. A., Opdenakker, G., van Kooyk, Y., Figdor, C., Willemze, R. (1999) Biology of IL-8-induced stem cell mobilization. Ann. N. Y. Acad. Sci. 872, 71-82
19. Van den Steen, P., Proost, P., Wuyts, A., Van Damme, J., Opdenakker, G. (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood 96, 2673-2681.
20. Carlo-Stella, C., Di Nicola, M., Longoni, P., Cleris, L., Lavazza, C., Milani, R., Milanesi, M., Magni, M., Pace, V., Colotta, F., Avanzini, M., Formelli, F., Gianni, A. (2007) Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice ad nonhuman primates. Stem Cells 25, 252-261.
21. Papayannopoulou, T., Nakamoto, B. (1993) Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc. Natl. Acad. Sci. USA 90, 9374-9378.
22. Selleri, C., Montuori, N., Ricci, P., Visconte, V., Baiano, A., Carriero, M. V., Rotoli, B., Rossi, G., Ragno, P. (2006) In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res. 66, 10885-10890.
23. Hattori, K., Heissig, B., Tashiro, K., Honjo, T., Tateno, M., Shieh, J-H., Hackett, N. R., Quitoriano, M. S., Crystal, R. G., Rafii, S., Moore, M. A. S. (2001) Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354-3360.
24. da Silva, M., Pimentel, P., Carvalhais, A., Barbosa, I., Machado, A., Campilho, F., Sousa, S., Miranda, N., da Costa, F., Campos, A., Vaz, C., Antas, J., Passos-Coehlho, J. (2004) Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection. Bone Marrow Transplant. 34, 683-691.
25. Mueller, Y., Cramer, D., Huang, Y., Exner, B., Ildstad, S. (2002) Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential. Transplantation 73, 1177-1185.
26. Moya, R., Espigado, I., Parody, R., Carmona, M., Marquez, F., De Blas, J. (2006) Evaluation of readmissions in hematopoietic stem cell transplant recipients. Transplant. Proc. 38, 2591-2592.
27. Semerad, C., Christopher, M., Liu, F., Short, B., Simmons, P., Winkler, I., Levesque, J., Chappel, J., Ross, F., Link, D. (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106, 3020-3027.
28. Zhang, Y., Wittner, M., Bouamar, H., Harrier, P., Vainchenker, W., Louache, F. (2007) Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+ cells. Stem Cells 25, 211-219.
29. Semerad, C., Liu, F., Gregory, A., Stumpf, K., Link, D. (2002) G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17, 413-423.
30. Link, D. (2005) Neutrophil homeostasis: a new role for stromal cell-derived factor-1. Immunol. Res. 32, 169-178.
31. Christopherson II, K. W., Uralil, S., Porecha, N. K., Zabriskie, R. C., Kidd, S., Ramin, S. (2006) G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells. Exp. Hematol. 34, 1060-1068.
32. Winkler, I., Levesque, J. (2006) Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp. Hematol. 34, 996-1009.
33. Christopherson II, K. W., Hangoc, G., Mantel, C., Broxmeyer, H. (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305, 1000-1003.
34. Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R., Arenzana-Seisdedos, F., Fujii, N., Sandbank, J., Zipori, D, Lapidot, T. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694.
35. Tsugiki, M., Kobayashi, Y., Kawasaki, T., Yoshimi, T. (1998) Identification of bile canalicular cell surface antigen HAM.4 as dipeptidyl peptidase IV (DPPIV) and characterization of its role in hepatic regeneration after partial hepatectomy in rats. Dig. Dis. Sci. 43, 2591-2600.
36. Iwaki-Egawa, S., Watanabe, Y., Fujimoto, Y. (1998) Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. J. Biochem. 124, 428-433.
37. Levy, M., McCoughan, G. W., Abbott, C. A., Park, J., Cunningham, A., Müller, E. R., Rettig, W. J., Gorrell, M. (1999) Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodeling interface in human cirrhosis. Hepatology 29, 1768-1778.
38. Pereira, D., Gomes, L., El-Cheikh, M., Borojevic, R. (2003) Dipeptidyl peptidase IV (CD26) activity in the hematopoietic system: differences between the membrane-anchored and the released enzyme activity. Braz. J. Med. Biol. Res. 36, 567-578.
39. Löster, K., Zeilinger, K., Schuppan, D, Reutter, W. (1995) The cysteine-rich region of dipeptidyl peptidase IV (CD26) is the collagen-binding site. Biochem. Biophys. Res. Commun. 217, 341-348.
40. Fan, H., Meng, W., Kilian, C., Grams, S., Reutter, W. (1997) Domain-specific N-glycosylation of the membrane glycoprotein dipeptidylpeptidase IV (CD26) influences its subcellular trafficking, biological stability, enzyme activity and protein folding. Eur. J. Biochem. 246, 243-251.
41. Smith, R., Talhouk, J., Brown, E., Edgar, S. (1998) The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding. AIDS Res. Hum. Retroviruses 14, 851-868.
42. Christopherson II, K. W., Hangoc, G., Broxmeyer, H. E. (2002) Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1{α}-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169, 7000-7008.
43. Hopsu-Havu, V., Glaner, G. (1966) A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide. Histochimie 7, 197-201.
44. Hong, W., Petell, J., Swank, D., Sanford, J., Hixson, D. C., Doyle, D. (1989) Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels. Exp. Cell Res. 182, 256-266.
45. Kameoka, J., Ichinohasama, R., Inoue, H., Yamamoto, J., Yokoyama, H., Tomiya, Y., Yamada, M., Ishizawa, K., Harigae, H., Sawai, T., Sasaki, T. (2006) CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma. Leuk. Lymphoma 47, 2181-2188.
46. Carbone, A., Cozzi, M., Gloghini, A., Pinto, A. (1994) CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Hum. Pathol. 25, 1360-1365.
47. Hegen, M., Niedobitek, G., Klein, C. E., Stein, H., Fleischer, B. (1990) The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J. Immunol. 144, 2908-2914.
48. Torimoto, Y., Dang, N., Vivier, E., Tanaka, T., Schlossman, S., Morimoto, C. (1991) Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J. Immunol. 147, 2514-2517.
49. Hegen, M., Kameoka, J., Dong, R. P., Schlossman, S. F., Morimoto, C. (1997) Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology 90, 257-264.
50. Bristol, L., Sakaguchi, K., Appella, E., Doyle, D., Takács, L. (1992) Thymocyte costimulating antigen is CD26 (dipeptidyl-peptidase IV): co-stimulation of granulocyte, macrophage, and T lineage cell proliferation via CD26. J. Immunol. 149, 367-372.
51. Holst, J., Deacon, C. (1998) Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. Diabetes 47, 1663-1670.
52. Augustyns, K., Bal, G., Thonus, G., Belyaev, A., Zhang, X., Bollaert, W., Lambier, A., Durinx, C., Goossens, F., Haemers, A. (1999) The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors. Curr. Med. Chem. 6, 311-327.
53. Hoffmann, T., Faust, J., Neubert, K., Ansorge, S. (1993) Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett. 336, 61-64.
54. Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M., Ditto, M., Nguyen, N., Boykins, R., Unsworth, E., Norcross, M. (1997) Regulation of the receptor specificity and of the function of the chemokine RANTES by dipeptidyl peptidase IV (CD-26)-mediated cleavage. J. Exp. Med. 186, 1865-1872.
55. Van Coillie, E., Proost, P., Van Aelst, I., Struyf, S., Polfliet, M., De Meester, I., Harvey, D. J., Van Damme, J., Opendakker, G. (1998) Functional comparison of two human monocyte chemotatic protein-2 isoforms, roles of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37, 12672-12680.
56. Lambier, A., Proost, P., Durinx, C., Bal, G., Senten, K., Augustyns, K., Schrape, S., Van Damme, J., De Meester, I. (2001) Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J. Biol. Chem. 276, 29839-29845.
57. Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., Tesio, M., Samstein, R. M., Goichberg, P., Spiegel, A, Elson, A., Lapidot, T. (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12, 657-664.
58. Levesque, J-P., Hendy, J., Takamatsu, Y., Simmons, P. J., Bendall, L. J. (2003) Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111, 187-196.
59. Rao, R., Betz, T., Lamont, D., Kim, M., Shaw, S., Froio, R., Baleux, F., Arenzana-Seisdedos, F., Alon, R., Luscinskas, F. (2004) Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1α and attenuates subsequent T lymphocyte transendothelial migration. J. Exp. Med. 200, 713-724.
60. Kim, H. K., De La Luz Sierra, M., Williams, C. K., Gulino, A. V., Tosato, G. (2006) G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 108, 812-820.
61. Winkler, I. G., Hendy, J., Coughlin, P., Horvath, A., Levesque, J-P. (2005) Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. J. Exp. Med. 201, 1077-1088.
62. Christopherson II, K. W., Cooper, S., Broxmeyer, H. (2003) Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 101, 4680-4686.
63. Christopherson II, K. W., Cooper, S., Hangoc, G., Broxmeyer, H. (2003) CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice. Exp. Hematol. 31, 1126-1134.
64. Epstein, R. (2004) The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies. Nat. Rev. Cancer 4, 901-909.
65. Pacheco, R., Martinez-Navio, J., Lejeune, M., Climent, N., Olivatt, H., Gatell, J., Gallart, T., Mallol, J., Lluis, C., Franco, R. (2005) CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc. Natl. Acad. Sci. USA 102, 9583-9588.
66. Morimoto, C., Schlossman, S. (1998) The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161, 55-70.
67. De Meester, I., Vanham, G., Kestens, L., Vanhoof, G., Bosmans, E., Gigase, P., Scharpe, S. (1994) Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24, 566-570.
68. Dong, R., Kameoka, J., Hegen, M., Tanaka, T., Xu, Y., Schlossman, S., Morimoto, C. (1996) Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response J. Immunol. 156, 1349-1355.
69. Gaspar, H., Bjorkegren, E., Parsley, K., Gilmour, K., King, D., Sinclair, J., Zhang, F., Giannakopoulos, A., Adams, S., Fairbanks, L. D., Gaspar, J., Henderson, L., Xu-Bayford, J. H., Davies, E., Veys, P., Kinnon, C., Thrasher, A. (2006) Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol. Ther. 14, 505-513.
70. Sharoyan, S., Antonyan, A., Mardanyan, S., Lupidi, G., Cristalli, G. (2006) Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase. Acta Biochim. Pol. 53, 539-546.
71. Seguin-Devaux, C., Hanriot, D., Dailloux, M., Latger-Cannard, V., Zannad, F., Mertes, P., Longrois, D., Devaux, Y. (2005) Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression. Mol. Cell. Endocrinol. 245, 67-76.
72. Iwata, M., Eshima, Y., Kagechika, H. (2003) Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 15, 1017-1025.
73. Bauvois, B., Djavaheri-Mergny, M., Rouillard, D., Dumont, J., Wietzerbin, J. (2000) Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene 19, 265-272.
74. Irvine, A., Berney, J., Francis, G. (1990) Dissociation of the proliferation and differentiation stimuli of granulocyte colony-stimulating factor (G-CSF). Leukemia 4, 203-209.
75. Ballin, A., Lehman, D., Sirota, P., Litvinjuk, U., Meytes, D. (1998) Increased number of peripheral blood CD34+ cells in lithium-treated patients. Br. J. Haematol. 100, 219-221.
76. Green, B., Irwin, N., Duffy, N., Gault, V., O'Harte, F. P., Flatt, P. R. (2006) Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. Eur. J. Pharmacol. 547, 192-199.
77. Lindsay, J., Duffy, N., McKillop, A., Ardill, J., O'Harte, F., Flatt, P., Bell, P. (2005) Inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes. Diabet. Med. 22, 654-657.
78. Mest, H. (2006) Dipeptidyl peptidase-IV inhibitors can restore glucose homeostasis in type 2 diabetics via incretin enhancement. Curr. Opin. Investig. Drugs 7, 338-343.
79. Miller, S., St Onge, E. (2006) Sitagliptin: a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Ann. Pharmacother. 40, 1336-1343.
80. Ahren, B. (2006) Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties. Expert Opin. Investig. Drugs 15, 431-442.
81. Nakamura, T., Uchiyama, S., Yamazaki, M., Iwata, M. (2006) Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation. Thromb. Res. 119, 511-516.
82. Hofer, M., Pospisil, M., Weiterova, L., Znojil, V., Vacha, J., Hola, J., Vacek, A., Pipalova, I. (2001) Combination of drugs elevating extracellular adenosine with granulocyte colony-stimulating factor promotes granulopoietic recovery in the murine bone marrow after 5-fluorouracil treatment. Physiol. Res. 50, 521-524.
83. Wang, T., Mentzer, R. J., Van Wylen, D. (1992) Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am. J. Physiol. 263, H552-H558.
84. Hegedus, K., Keresztes, T., Fekete, I., Molnar, L. (1997) Effect of i.v. dipyridamole on cerebral blood flow, blood pressure, plasma adenosine and cAMP levels in rabbits. J. Neurol. Sci. 148, 153-161.
85. Robak, T. (2001) Cladribine in the treatment of chronic lymphocytic leukemia. Leuk. Lymphoma 40, 551-564.
86. Kay, N. (2006) Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia. Semin. Hematol. 43, S50-S54.
87. Gandhi, V., Plunkett, W. (2002) Cellular and clinical pharmacology of fludarabine. Clin. Pharmacokinet. 41, 93-103.
88. Spiers, A. (1996) Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases. Haematologia (Budap.) 27, 55-84.
89. Riksen, N., Barrera, P., van den Broek, P., van Riel, P., Smits, P., Rongen, G. (2006) Methotrexate modulates the kinetics of adenosine in humans in vivo. Ann. Rheum. Dis. 65, 465-470.
90. Jindra, P., Koza, V., Lysak, D., Vozobulova, V., Steinerova, K. (2005) Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF. Bone Marrow Transplant. 35, 729-730.
91. Visani, G., Lemoli, R., Tosi, P., Martinelli, G., Testoni, N., Ricci, P., Piccaluga, P., Pastano, R., Liopardi, G., Dizdari, A., Motta, M., Rizzi, S., Tura, S. (1999) Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients. Br. J. Haematol. 105, 775-779.
92. Tian, C., Bagley, J., Forman, D., Iacomini, J. (2006) Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 13, 652-658.
93. Peranteau, W., Endo, M., Adibe, O. O., Merchant, A., Zoltick, P. W., Flake, A. W. (2006) CD26 inhibition enhances allogeneic donor cell homing and engraftment after in utero hematopoietic cell transplantation. Blood 108, 4268-4274.
94. Korom, S., de Meester, I., Belyaev, A., Schmidbauer, G., Schwemmle, K. (2003) CD26/DPP IV in experimental and clinical organ transplantation. Adv. Exp. Med. Biol. 524, 133-143.
95. Triplitt, C., Wright, A., Chiquette, E. (2006) Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus. Pharmacotherapy 26, 360-374.
96. Lenhard, J., Croom, D., Minnick, D. (2004) Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments. Biochem. Biophys. Res. Commun. 324, 92-97.
97. Baptista, T., Lacruz, A., de Mendoza, S., Guillen, M., Burguera, J. L., de Burguera, M., Hernández, L. (2000) Endocrine effects of lithium carbonate in healthy premenopausal women: relationship with body weight regulation. Prog. Neuropsychopharmacol. Biol. Psychiatry 24, 1-16.
98. Hofer, M., Pospisil, M., Znojil, V., Vacek, A., Weiterova, L., Hola, J., Vacha, J. (2002) Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony-stimulating factor. Eur. J. Haematol. 68, 4-11.
99. Hofer, M., Weiterova, L., Vacek, A., Znojil, V., Pospisil, M., Vacha, J. (2003) Elevation of extracellular adenosine mobilizes hematopoietic progenitor cells and granulocytes into peripheral blood and enhances the mobilizing effects of granulocyte colony-stimulating factor. Eur. J. Haematol. 71, 204-210.
100. Rubocki, R., Parsa, J. R., Hershfield, M. S., Sanger, W., Pirruccello, S., Santisteban, I., Gordon, B., Strandjord, S., Warkentin, P. I., Coccia, P. F. (2001) Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. Blood 97, 809-811.
101. Carbonaro, D., Jin, X., Cotoi, D., Mi, T., Yu, X., Skelton, D., Dorey, F., Kellems, R., Blackburn, M., Kohn, D. (2008) Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunological reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion. Blood, Epub ahead of print.
102. Sekhsaria, S., Fleisher, T., Vowells, S., Brown, M., Miller, J., Gordon, I., Blaese, R., Dunbar, C., Leitman, S., Malech, H. (1996) Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients. Blood 88, 1104-1112.
103. Campbell, T., Broxmeyer, H. (2008) CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Front. Biosci. 13, 1795-1805.
104. Focosi, D., Kast, R., Metelli, M., Benedetti, E., Galimberti, S., Papineschi, F., Petrini, M. (2008) Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: a report in a case of delayed graft failure. Leuk. Res., in press.
105. Chan, K., Grimley, M., Taylor, C., Wall, D. (2008) Early identification and management of graft failure after unrelated cord blood transplantation. Bone Marrow Transplant., Epub ahead of print.
106. Zou, L., Barnett, B., Safah, H., Larussa, V., Evdemon-Hogan, M., Mottram, P., Wei, S., David, O., Curiel, T., Zou, W. (2004) Bone marrow is a reservoir for CD4CD25 regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64, 8451-8455.